4.6 Article

Low-dose urokinase thrombolytic therapy for patients with acute intermediate-high-risk pulmonary embolism: A retrospective cohort study

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Clinical update on thrombolytic use in pulmonary embolism: A focus on intermediate-risk patients

Hannah Eberle et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2018)

Article Cardiac & Cardiovascular Systems

Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism

Stavros V. Konstantinides et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Global Burden of Thrombosis Epidemiologic Aspects

Aaron M. Wendelboe et al.

CIRCULATION RESEARCH (2016)

Article Medicine, General & Internal

Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism

Guy Meyer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Cardiac & Cardiovascular Systems

Moderate Pulmonary Embolism Treated With Thrombolysis (from the MOPETT Trial)

Mohsen Sharifi et al.

AMERICAN JOURNAL OF CARDIOLOGY (2013)

Article Medicine, General & Internal

Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism

S Konstantinides et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)